Therefore, the purpose of this study was to conduct a meta-analysis on the prognostic value of RASSF1A methylation status in prostate cancer, and the relationship between RASSF1A methylation and pathological stage, Gleason score, and PSA level. Here, RASSF1 is linked to prostate carcinoma.